Comparative evaluation of different rat models with co-existing diabetes-mellitus and hypertension

Indian Journal of Physiology and Pharmacology

Volumn 44, Issue 2, 2000, Pages 125-135

  Hakim, Zeenat S ^a   Goyal, Ramesh K ^a  

^a L M COLLEGE OF PHARMACY   (India)

Author keywords

Diabetes mellitus; DOCA hypertension; Hyperinsulinemia; Hypertension; Streptozotocin

Indexed keywords

DEOXYCORTICOSTERONE ACETATE; GLUCOSE; INSULIN; SODIUM CHLORIDE; STREPTOZOCIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MODEL; DRUG MECHANISM; GLUCOSE HOMEOSTASIS; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; NEWBORN; NONHUMAN; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STREPTOZOCIN DIABETES; SYMPTOMATOLOGY;

ANIMALS; ANIMALS, NEWBORN; ANTIHYPERTENSIVE AGENTS; AREA UNDER CURVE; BLOOD GLUCOSE; CREATININE; DESOXYCORTICOSTERONE; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; GLUCOSE TOLERANCE TEST; HEMODYNAMIC PROCESSES; HYPERTENSION; INSULIN; RATS; RATS, INBRED SHR; RATS, WISTAR;

EID: 0034042558     PISSN: 00195499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Reaven GM. Role of insulin resistance in human disease. Banting Lecture. Diabetes 1988; 37: 1595-1607.
2. Breglund G, Ljungman S, Harlford M. Type of obsity and blood pressure. Hypertension 1982; 4: 692-696.
3. Welborn TA, Breckenridge A, Rubinstein AH, Dollery CT, Fraswer TR. Serum insulin in essential hypertension and in peripheral vascular disease. Lancet 1966; 1: 1336-1337.
4. Levy J, Zemel MB, Sowers JR. Role of cellular metabolism in abnormal glucose metabolism and diabetic-hypertension. Am J Med 1989; 87 (Suppl 6A): 7S-16S.
5. Reaven GM, Hoffman BB. Hypertension as a disease of carbohydrate and lipoprotein metabolism. Am J Med 1989; 87: (Suppl 6A): 2S-6S.
6. Modan M, Halkin H, Alomog S, Lusky A, Eskol A, Shefi M, Shitrit A, Fuchol. Hyperinsulinemia: a link between hypertension, obesity, and glucose intolerance. J Clin Invest 1985; 75: 809-817.
7. Christensen CK, Krussad LR, Mongensen CE. Increased blood pressure in diabetes: Essential hypertension or diabetic nephropathy? Scand J Clin Lab Invest, 1987; 47: 363-370.
8. De Fronzo RA, Cooke CR, Andres R, Falona GR, Davis PJ. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest 1975; 55: 845-855.
9. Landsberg L, Krieger DR. Obesity, metabolism and the sympathetic nervous system. Am J Hypertens 1989; 2: 125S-132S.
10. Cruz AB, Amatuzio DS, Grande F, Hay LJ. Effect of intra arterial insulin on tissue cholesterol and fatty acids in alloxan diabetic dogs. Circ Res 1961; 9: 39-43.
11. Pfeifle B, Ditschuneit H. Effect of insulin on the growth of cultured arterial smooth muscle cells. Diabetologia 1981; 20: 155-158.
12. Internatinal Prospective Primary Prevention Study in Hypertension Collaborative Group: Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blockers oxprenolol. J Hypertens 1985; 3: 370-392.
13. Wilhelmsen L, Berglund G, Elmfeldt D et al. Beta blockers versus diuretics in hypertensive men: main results from the HAPPY trial. J Hypertens 1987; 5: 561-572.
14. Weir GC, Clore ET. Islet secretion in a new experimental model of NIDDM. Diabetes 1981; 30: 590-595.
15. Seifter S, Novic B, Muntwyler E. The estimation of glucogen with anthrone reagent. Arch Biochem 1950; 25: 191-200.
16. Shah TS, Satia MC, Gandhi TP, Bangaru RA, Goyal RK. Effects of chronic nifedipine treatment on streptozotocin-induced diabetic rats. J Cardiovasc Pharmacol 1995; 26: 6-12.
17. Sevak AR, Goyal RK. Effects of chronic treatment with lisinopril on cardiovascular complications in streptozotocin-induced diabetic and DOCA hypertensive rats. Pharm Res 1996; 34: 201-209.
18. Kawashima H. Chronic hypertension induced by STZ in rats. Naunyn Schiemedbergs. Arch Pharmacol 1978; 305: 123-126.
19. 2 in rats with STZ induced diabetes. Naunyn Schimedbergs Arch Pharmacol 1983; 322: 290-294.
20. Sasaki S, Bunag RD. Insulin reverses hypertension and hypothalamic depression in streptozotocin diabetic rats Hypertension 1983; 5: 34-40.
21. Bunag RD, Tomita T, Saski S. Streptozotocin diabetic rats are hypertensive despite reduced hypothalamic responsiveness. Hypertension 1982; 4: 556-565.
22. Erman A, Van Dyke DJ, Chen-GAL b, Giler IDS, Rosenfeld JB, Bener G. ACE activity in serum, lung and kidney of diabetic rats. Eur J Clin Invest 1993; 23: 615-620.
23. Rodgers RL, Breault PH, Sessa WC Jr, Chichestar CO. Depressor effects of diabetes in spontaneously hypertensive rat: role of vascular reactivity and prolyl hydroxylase and lysyl oxidase activities. Life Sci 1985; 37: 2237-2247.
24. Kusaka M, Kishi K, Sokabe H. Does so-called streptozotocin hypertension exist in rats? Hypertension 1987; 10: 517-521.
25. Hebden RA, Todd ME, Tnag C, Gowen B, McNeill JH. Association of DOCA hypertension with induction of atherosclerosis in rats with short-term diabetes mellitus. Am J Physiol 1990; 251: F563-F575.
26. Dai S, McNeill JH. Myocardial performance of streptozotocin diabetic and DOCA-hypertensive rats. Am J Physiol 1992; 263: H1798-1805.
27. Schenk J, McNeill JH. The pathogenesis of DOCA-salt hypertension. J Pharmacol Toxicol Meth 1992; 27: 161-170.
28. Ferrario CM, Tramposch A, Kawano Y, Brosnihan KB. Sodium balance and the reflex regulation of baroreflex function. Circulation 1987; 75(Suppl I) 1141-1148.
29. Ueno Y, Mohara O, Brosniham KB, Ferrario CM. Characteristics of hormonal and neurogenic mechanisms of DOCA-induced hypertension. Hypertension 1988; 11: 172-177.
30. Itaya Y, Suzuki H, Matsukawa S, Kondo K, Saruta T. Central renin-angiotensin system and the pathogenesis of DOCA-salt hypertension in rats. Am J Physiol 1988; 251: H261-H268.
31. Takeda K, Nakamura Y, Okajima H, Hayashi J, Kawasaki S, Lee L, Sasaki S, Nakagawa M. Attenuated cardiovascular and sympathetic nerve responses to aortic nerve stimulation in DOCA-salt hypertensive rats. J Hypertension 1988; 6: 559-563
32. Ouchi Y, Yazaki Y, Tsai R, Ashida T. Pressor response to vasopressin and norepinephrine in DOCA-salt hypertensive and prehypertensive rats. Tohuko J Exp Med 1988; 154: 125-133.
33. Takeda K, Nakamura Y, Hayashi J, Kawasaki S, Nahata T, Oguro M, Sasaid S, Nakagawa M. Effects of salt and DOCA on hypothalamic and baroreflex control of blood pressure. Clin Exp Hypertens 1988; 10 (Suppl 1): 289-299.
34. Hulman S, Falkner B, Chen YQ. Insulin resistance in the spontaneously hypertensive rat. Metabolism 1991; 40: 359-361.
35. Buchanan TA, Youn JH, Campese VW, Sipos GF. Enhanced glucose tolerance in spontaneously hypertensive rats: pancreatic beta-cell hyperfunction with normal insulin sensitivity. Diabetes 1992; 41: 872-878.
36. Frontoni S, Ohman L, Haywood JR, De Fronzo RA, Rossetti L. In vivo insulin action in genetic models of hypertension. Am J Physiol 1992; 262: E191-E196.
37. Reaven GM, Chang H. Relationship between blood pressure, plasma insulin and triglyceride concentration and insulin action in spontaneously hypertensive and Wistar Kyoto rats. Am J Hypertens 1991; 4: 34-38.
38. Endre T, Mattiasson I, Berglud G, Hulthen UL. Insulin and renal sodium retention in hypertension-prone men. Hypertension 1994; 23: 313-319.
39. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system acitivity in normal man. Diabetes 1981; 30: 219-225.
40. Banskota NK, Taub R, Zeller K, Olson P, King GL. Insulin, insulin like GF-i and PDGF act additively in the induction of the prooncogenic c-myc and cellular proliteration in culture bovine aortic smooth muscle cells. Mol Endocrinol 1989; 3: 1183-1190.
41. Boon NA, Harper C, Aronson JK, Grahame-Smith DG. Cation transport functions in vivo in patients with untreated essential hypertension: a comparison of erythrocytes and leukocytes Clin Sci 1985; 68: 511-515.
42. Standley PR, Bakir MH, Sowers JR. Vascular insulin abnormalities, hypertension and accelerated atherogrenesis. Am J Kidney Dis 1993; 21 (Suppl 3): 39-46.
43. Hofteizer V, Carpenter AM. Comparison of streptozotocin-induced diabetes in the rat including volumetric quantitation of the pancreatic islets. Diabetologia 1973; 9: 178-184.
44. Bonora E, Zavarani I, Coscelli C, Butturini U. Decreased hepatic insulin extraction in subjects with mild glucose intolerance. Metabolism 1983; 32: 438-444.
45. Savaress JJ, Berkowitz BA. Beta-adrenoceptors, in diabetic rat heart. Life Sci 1979; 25: 2075-2078.
46. Goyal RK, Rodrigues B, McNeill JH. Effects of trilodo-1-thyronine on cardiac responses to adrenergic agonists in STZ-induced diabetic rats. Gen Pharmac 1987; 18: 257-262.
47. Rodrigues B, Goyal RK, McNeill JH. Effects of hydralazine on STZ induced diabetic rats-prevention of hyperlipidaemia and improvement in cardiac function. J Phamac Expt Ther 1986; 237: 299-307.
48. Ditzel J, Standi E. The problem of tissue oxygenation in diabetes mellitus. Acta Med Scan 1975; 49: 578-581.
49. Tomlinson AC, Gradinar SM, Bennet T. Blood pressure in STZ treated Brattleboro and Longevans rats. Am J Physiol 1990; 258: R852-R859.
50. Evan 1984; 7: 78-89. AP, Mong SA. The effect of STZ induced diabetes on kidney. Renal Physiol 1984; 7: 78-89.
51. Evan 1984; 7: 78-89. AP, Mong SA. The effect of STZ induced diabetes on kidney. Renal Physiol 1984; 7: 78-89.
52. Thomson AH, Kelly JG, Whiting B. Lisinopril population pharmacokinetics in elderly and renal disease patients with hypertension. Br J Clin Pharmacol 1989; 27: 58-65.